Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Open-label, Randomized, Active-Controlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 and AZD6563 Vaccine (ARTEMIS-C)

NCT06147063 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06147063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06147063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Open-label, Randomized, Active-Controlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 and AZD6563 Vaccine (ARTEMIS-C)
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
November 27, 2023
Completion date
March 27, 2025
Enrollment
243 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection